Methods for the rapid preparation of labeled glycosylamines from complex matrices using molecular weight cut off filtration and on-filter deglycosylation

US11150248B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11150248-B2
Application numberUS-201716314554-A
CountryUS
Kind codeB2
Filing dateJun 19, 2017
Priority dateJul 1, 2016
Publication dateOct 19, 2021
Grant dateOct 19, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Methods for preparing labeled glycosylamines from a complex matrix are provided. The methodology includes the steps of: denaturing glycoproteins in a complex matrix to form a denatured complex matrix mixture; loading the denatured complex matrix mixture onto a MWCO filtration device; adding a glycosidase enzymatic solution onto the MWCO filtration device to form a deglycosylated complex matrix mixture comprising glycosylamines; collecting glycosylamines released from the MWCO filtration device; and derivatizing glycosylamines with a rapid tagging reagent to form a plurality of labeled glycosylamines suitable for detection in various liquid chromatography systems and detectors.

First claim

Opening claim text (preview).

I claim: 1. A method for preparing labeled glycosylamines from a complex matrix, comprising the steps of: denaturing glycoproteins in a complex matrix by mixing the complex matrix with a denaturing solution comprising a buffer and a surfactant and heating to form a denatured complex matrix mixture; diluting and loading the denatured complex matrix mixture onto a MWCO filtration device and filtering the denatured complex matrix mixture; subsequently adding a glycosidase enzymatic solution comprising a glycosidase enzyme and a non-nucleophilic buffer compound onto the MWCO filtration device, containing the diluted denatured complex matrix mixture, and incubating the MWCO filtration device wherein the glycoproteins on the MWCO filtration device are deglycosylated and form a deglycosylated complex matrix mixture comprising glycosylamines; collecting glycosylamines released from the MWCO filtration device; and derivatizing glycosylamines with a rapid tagging reagent to form a plurality of labeled glycosylamines. 2. The method of claim 1 , wherein the MWCO filtration device is heated. 3. The method of claim 1 , wherein the denatured complex matrix mixture is loaded onto the MWCO filtration device by a liquid handling system. 4. The method of claim 1 , further comprising the step of centrifuging the denatured complex matrix mixture. 5. The method of claim 1 , further comprising the step of diluting the deglycosylated complex matrix mixture. 6. The method of claim 1 , wherein the glycosylamines flow through the MWCO filtration device to a filtrate collection device. 7. The method of claim 1 , wherein the plurality of labeled glycosylamines are detected in a liquid chromatography system. 8. The method of claim 1 , wherein the MWCO filtration device is a 96-well filter plate. 9. The method of claim 1 , wherein the complex mixture is selected from plasma, cellular lysates, biofluids and/or tissue extracts. 10. The method of claim 1 , wherein the non-nucleophilic buffer compound is a zwitterionic non-nucleophilic buffer compound and wherein the buffer compound has a pKa between about 7 and about 9. 11. The method of claim 1 , wherein the non-nucleophilic buffer compound is a non-nucleophilic cationic buffer compound. 12. The method of claim 1 , further comprising analyzing the plurality of labeled glycosylamines by mass spectrometric detection. 13. The method of claim 1 , wherein the denaturing solution further comprises a thiol reducing agent in a concentration between 1 to 100 mM. 14. A method for preparing labeled glycosylamines from a complex matrix, comprising the steps of: denaturing glycoproteins in a complex matrix by mixing the complex matrix with a denaturing solution comprising a buffer, a thiol reducing agent in a concentration between 1 to 100 mM, and a surfactant and heating to form a denatured complex matrix mixture; diluting and loading the denatured complex matrix mixture onto a MWCO filtration device and filtering the denatured complex matrix mixture; subsequently adding a glycosidase enzymatic solution comprising a glycosidase enzyme and a non-nucleophilic zwitterionic buffer compound having a pKa between about 7 and about 9 or a non-nucleophilic cationic buffer compound onto the MWCO filtration device, containing the diluted denatured complex matrix mixture, and incubating the MWCO filtration device wherein the glycoproteins on the MWCO filtration device are deglycosylated and form a deglycosylated complex matrix mixture comprising glycosylamines; collecting glycosylamines released from the MWCO filtration device; and derivatizing glycosylamines with a rapid tagging reagent to form a plurality of labeled glycosylamines. 15. The method of claim 14 , wherein the glycosidase enzymatic solution comprises the non-nucleophilic zwitterionic buffer compound having a pKa between about 7 and about 9. 16. The method of claim 14 , wherein the non-nucleophilic cationic buffer compound.

Assignees

Inventors

Classifications

  • Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins · CPC title

  • G01N30/06Primary

    Preparation · CPC title

  • N-glycosides · CPC title

  • by a combination of two or more processes of different types · CPC title

  • Labelling of peptides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11150248B2 cover?
Methods for preparing labeled glycosylamines from a complex matrix are provided. The methodology includes the steps of: denaturing glycoproteins in a complex matrix to form a denatured complex matrix mixture; loading the denatured complex matrix mixture onto a MWCO filtration device; adding a glycosidase enzymatic solution onto the MWCO filtration device to form a deglycosylated complex matrix …
Who is the assignee on this patent?
Waters Technologies Corp
What technology area does this patent fall under?
Primary CPC classification G01N33/6842. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).